Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy

• Chrysostomi Gialeli,
• Emre Can Tuysuz,
• Johan Staaf,
• Safa Guleed,
• Veronika Paciorek,
• Matthias Mörgelin,
• Konstantinos S. Papadakos,
• Anna M. Blom

Affiliations

Chrysostomi Gialeli

Department of Translational Medicine, Lund University

Emre Can Tuysuz

Department of Translational Medicine, Lund University

Johan Staaf

Division of Oncology, Department of Clinical Sciences Lund, Lund University

Safa Guleed

Department of Translational Medicine, Lund University

Veronika Paciorek

Department of Translational Medicine, Lund University

Matthias Mörgelin

Colzyx AB

Konstantinos S. Papadakos

Department of Translational Medicine, Lund University

Anna M. Blom

Department of Translational Medicine, Lund University